VIR: Vir Biotechnology Net earnings per share for the last 12 months

Public company logo of Vir Bio (VIR)

Vir Biotechnology, Inc. (VIR) relies on years of antibody development to combat infections. The rolling specific profit history demonstrates revenue dynamics, where the metric level stands at -1.26. The defensive nature of the niche ensures stable demand regardless of economic conditions. A neutral geopolitical backdrop and a humanitarian mission make the asset resilient to external trade restrictions.

VIR vir.bio Net earnings per share for the last four quarters (07/04/2022 - 11/15/2026)

Metric breakdowns and analytics for Vir Corp (VIR)

- current quotes and average value forecast:
General company analysis:Vir Biotechnology - VIR
Manufactured products of Vir Bio

Institutional investors assess the attractiveness of Vir Biotechnology, Inc. (VIR) through the ability of automated antibody synthesis to generate real revenue that exceeds clinical trial costs. By analyzing the annual net income per share trend, which calculates the final financial result over 12 months divided by the total number of shares, one can determine the actual profitability of the business and confirm the fundamental stability of the asset.

Competing companies

Gilead - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Cidara Corp CDTX|Novavax Corp (NVAX) - Earnings per share for the last twelve months|CureVac N.V. - Earnings per share for the trailing year|Net earnings per share for the last 12 months VALN|Net earnings per share (EPS TTM) siga.com|Net earnings per share (EPS TTM) EBS|Net earnings per share for the last four quarters Atea Pharmaceuticals, Inc.|Net earnings per share (EPS TTM) IVVD (invivyd.com)|Enanta Pharmaceuticals, Inc (ENTA) - Net earnings per one share for the last twelve months|INO - Earnings per share for the last twelve months|Net earnings per share for the last four quarters hillevax.com HLVX|Kalaris Therapeutics (KLRS) - Earnings per share for the last twelve months|Dyadic International Inc (DYAI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months NanoViricides Inc.|Talphera Corp - Earnings per one share for the last 12 months|Net earnings per share for the last 12 months COCP (Cocrystal Pharma Inc)|Net earnings per share for the last four quarters Traws Therapeutics|Earnings per share for the last twelve months Dogwood Therapeutics DWTX|Net earnings per share for the trailing year Qualigen Therapeutics, Inc.|ALVR - Earnings per share for the last twelve months|vbivaccines.com (VBIV) - Net earnings per share for the last 12 months|VIRI (virios.com) - Net earnings per share for the last 12 months|VXRT - Net earnings per share for the last four quarters